Skip to main content
Contact Us
Subscribe
E-Edition
40°
Site search
Search
Menu
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
About Us
Contact Us
Advertise
Terms and Conditions
Privacy Policy
Home Delivery
Subscription Services
Place an Ad
Promote Your Event
Local Weather
News
Sports
Obits
Multimedia
Photo Galleries
Videos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Subscribe
Best of 2024
Archives
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Nanovibronix Inc
(NQ:
NAOV
)
0.9000
-0.0321 (-3.44%)
Streaming Delayed Price
Updated: 3:50 PM EDT, Mar 28, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Nanovibronix Inc
< Previous
1
2
Next >
NanoVibronix Signs Agreement for Research and Development of Next Generation PainShield and UroShield
March 28, 2024
From
NanoVibronix, Inc.
Via
Business Wire
NanoVibronix Featured in Your Bladder Health Magazine
December 06, 2023
From
NanoVibronix, Inc.
Via
Business Wire
NanoVibronix Enters into Letter of Intent with APOGEPHA Arzneimittel GmbH to Explore European Distribution Opportunity
December 04, 2023
From
NanoVibronix, Inc.
Via
Business Wire
NanoVibronix Announces Agreement for Clinical Study of UroShield at the University of Michigan
November 28, 2023
From
NanoVibronix, Inc.
Via
Business Wire
NanoVibronix Regains Nasdaq Compliance
November 21, 2023
From
NanoVibronix, Inc.
Via
Business Wire
NanoVibronix Issues Letter to Shareholders
November 14, 2023
From
NanoVibronix, Inc.
Via
Business Wire
NanoVibronix UroShield Products Available on NHS Drug Tariff Effective November 1
November 07, 2023
From
NanoVibronix, Inc.
Via
Business Wire
NanoVibronix Gains Approval for Inclusion of UroShield Products in NHS Prescription Services’ Drug Tariff
September 27, 2023
From
NanoVibronix, Inc.
Via
Business Wire
BioMedNewsBreaks – IBN’s BioMedWire Highlights NanoVibronix Inc.’s (NASDAQ: NAOV) $5M Private Placement
September 21, 2023
Via
Investor Brand Network
NanoVibronix Announces Presentation of Positive Independent Testing Results of UroShield at ICS Annual Meeting
September 06, 2023
From
NanoVibronix, Inc.
Via
Business Wire
NanoVibronix Announces $5 Million Private Placement Priced At-The-Market Under Nasdaq Rules
August 30, 2023
From
NanoVibronix, Inc.
Via
Business Wire
NanoVibronix Inc. (NASDAQ: NAOV) is One of Wednesday Morning’s Most Active Stocks
August 30, 2023
Via
Investor Brand Network
NanoVibronix Cites Positive Results from Independent Testing of UroShield
August 30, 2023
From
NanoVibronix, Inc.
Via
Business Wire
NanoVibronix Responds to CMS’ Determination for PainShield
August 29, 2023
From
NanoVibronix, Inc.
Via
Business Wire
NanoVibronix Applies for Inclusion of UroShield Products in NHS Prescription Services’ Drug Tariff
August 28, 2023
From
NanoVibronix, Inc.
Via
Business Wire
NanoVibronix Extends Distribution Agreement with Its Largest Distributor for PainShield and PainShield Plus
August 23, 2023
From
NanoVibronix, Inc.
Via
Business Wire
NanoVibronix Announces Distribution Agreement with Sports Medicine Supplier Mio-Guard
June 14, 2023
From
NanoVibronix, Inc.
Via
Business Wire
NanoVibronix Issues Letter to Shareholders
May 18, 2023
From
NanoVibronix, Inc.
Via
Business Wire
NanoVibronix Issues Letter to Shareholders
April 18, 2023
From
NanoVibronix, Inc.
Via
Business Wire
NanoVibronix Receives Positive Final Results of Independent Lifecycle Testing of PainShield Prompted by Centers for Medicare and Medicaid Services (CMS)
March 28, 2023
From
NanoVibronix, Inc.
Via
Business Wire
NanoVibronix Files Provisional U.S. Patent Application for UroShield Ultra
March 21, 2023
From
NanoVibronix, Inc.
Via
Business Wire
NanoVibronix Announces Positive Results from Independent Product Trial of UroShield for Patients with a Spinal Cord Injury
March 14, 2023
From
NanoVibronix, Inc.
Via
Business Wire
NanoVibronix Regains Nasdaq Compliance
March 03, 2023
From
NanoVibronix, Inc.
Via
Business Wire
NanoVibronix to Launch Rental Program for PainShield and UroShield
February 22, 2023
From
NanoVibronix, Inc.
Via
Business Wire
NanoVibronix Announces Reverse Stock Split
February 08, 2023
From
NanoVibronix, Inc.
Via
Business Wire
NanoVibronix Provides Update on Expanding Access to PainShield
January 18, 2023
From
NanoVibronix, Inc.
Via
Business Wire
NanoVibronix Announces Results of Annual Meeting of Stockholders Held Today
December 15, 2022
From
NanoVibronix, Inc.
Via
Business Wire
NanoVibronix Announces Partnership with Peak Medical, Ltd.
December 13, 2022
From
NanoVibronix, Inc.
Via
Business Wire
NanoVibronix Announces Closing of $2.4 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
December 01, 2022
From
NanoVibronix, Inc.
Via
Business Wire
NanoVibronix Announces $2.4 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
November 29, 2022
From
NanoVibronix, Inc.
Via
Business Wire
< Previous
1
2
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.